{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,21]],"date-time":"2026-11-21T20:35:55Z","timestamp":1795293355492,"version":"4.10.3"},"reference-count":47,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["Invest Radiol"],"published-print":{"date-parts":[[2021,6]]},"abstract":"<jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>The aim of this study was to determine the following in patients who have undergone magnetic resonance imaging with gadolinium-based contrast agents (GBCAs) and meet the proposed diagnostic criteria for gadolinium deposition disease (GDD): (1) the effectiveness of chelation therapy (CT) with intravenous Ca-diethylenetriaminepentaacetic acid in removing retained gadolinium (Gd) and factors affecting the amount removed; (2) the frequency of CT-induced Flare, that is, GDD diagnostic symptom worsening, and factors affecting Flare intensity; (3) whether, as reported in a separate cohort, GDD patients' serum cytokine levels differ significantly from those in healthy normal controls and change significantly in response to CT; and (4) whether urine Gd, Flare reaction, and serum cytokine findings in GDD patients are mimicked in non-ill patients described as having gadolinium storage condition (GSC).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and Methods<\/jats:title>\n                    <jats:p>Twenty-one GDD subjects and 3 GSC subjects underwent CT. Patients provided pre-CT and post-CT 24-hour urine samples for Gd content determination along with pre-CT and 24-hour post-CT serum samples for cytokine analysis. Patients rated potential Flare 24 hours after CT. Pre-CT and post-CT 24-hour urine Gd analyses and Luminex serum cytokine assays were performed blind to patients' GDD and GSC status and all other data except age and sex. Serum cytokine levels in a healthy normal control group of age- and sex-matched subjects drawn from Stanford influenza vaccination studies were measured once, contemporaneously with those of GDD and GSC patients, using the same Luminex assay.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Urine Gd amounts increased post-CT by 4 times or more after 87% of the 30 CT sessions. The most important factors appeared to be the time since the last GBCA dose and the cumulative dose received. Urine Gd amounts for GDD and GSC patients fell in the same ranges. All GDD patients, and no GSC patient, reported a Flare 24 hours post-CT. Linear regression found that Flare intensity was significantly predicted by a model including pre- and post-CT Gd amounts and the number of GBCA-enhanced magnetic resonance imaging. Post-CT, multiple cytokines showed strong positive relationships with GDD patients' Flare intensity in multivariable models. The pre-CT serum levels of 12 cytokines were significantly different in GDD patients compared with healthy flu vaccine controls. The small number of GSC patients precluded analogous statistical testing. Post-CT, GDD patients' serum levels of 20 cytokines were significantly decreased, and 2 cytokines significantly increased. These cytokines did not exhibit the same change pattern in the 3 GSC patients. The small number of GSC patients precluded statistical comparisons of GSC to GDD patients' results.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>In this preliminary study, 24-hour urine Gd content increased markedly and similarly in GDD and GSC patients after Ca-diethylenetriaminepentaacetic acid CT. Post-CT Flare reaction developed only in GDD patients. The current study is the second finding significantly different serum cytokine levels in GDD patients compared with healthy normal controls. These differences and the difference between GDD and GSC patients' Flare and cytokine responses to CT suggest some inflammatory, immunologic, or other physiological differences in patients with GDD. Further research into the treatment and physiological underpinnings of GDD is warranted.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/rli.0000000000000752","type":"journal-article","created":{"date-parts":[[2021,1,15]],"date-time":"2021-01-15T12:01:24Z","timestamp":1610712084000},"page":"374-384","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":19,"title":["Acute Chelation Therapy\u2010Associated Changes in Urine Gadolinium, Self-reported Flare Severity, and Serum Cytokines in Gadolinium Deposition Disease"],"prefix":"10.1097","volume":"56","author":[{"given":"Holden T.","family":"Maecker","sequence":"first","affiliation":[{"name":"Institute for Immunity, Transplantation, and Infection, Stanford University School of Medicine, Stanford, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janet C.","family":"Siebert","sequence":"additional","affiliation":[{"name":"CytoAnalytics, Denver, CO"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yael","family":"Rosenberg-Hasson","sequence":"additional","affiliation":[{"name":"Institute for Immunity, Transplantation, and Infection, Stanford University School of Medicine, Stanford, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorrin M.","family":"Koran","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Stanford, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel","family":"Ramalho","sequence":"additional","affiliation":[{"name":"Department of Radiology, Hospital Garcia de Orta, Almada, Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard C.","family":"Semelka","sequence":"additional","affiliation":[{"name":"Richard Semelka Consulting, PLLC, Chapel Hill, NC."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2021,1,15]]},"reference":[{"key":"bib1-20250802","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1007\/s11547-017-0757-3","article-title":"Gadolinium retention in the body: what we know and what we can do","volume":"122","year":"2017","journal-title":"Radiol Med"},{"key":"bib2-20250802","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.jacr.2019.11.009","article-title":"Gadolinium deposition disease: a new risk management threat","volume":"17","year":"2020","journal-title":"J Am Coll Radiol"},{"key":"bib3-20250802","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1001\/jamainternmed.2019.5284","article-title":"Risk of nephrogenic systemic fibrosis in patients with stage 4 or 5 chronic kidney disease receiving a group II gadolinium-based contrast agent: a systematic review and meta-analysis","volume":"180","year":"2020","journal-title":"JAMA Intern Med"},{"key":"bib4-20250802","doi-asserted-by":"crossref","first-page":"20140307","DOI":"10.1259\/bjr.20140307","article-title":"Advancing pharmacovigilance through academic-legal collaboration: the case of gadolinium-based contrast agents and nephrogenic systemic fibrosis\u2014a research on adverse drug events and reports (RADAR) report","volume":"87","year":"2014","journal-title":"Br J Radiol"},{"key":"bib5-20250802","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1148\/radiol.2020201644","article-title":"A breakthrough in gadolinum-based contrast agent hypersensitivity reactions","volume":"296","year":"2020","journal-title":"Radiology"},{"key":"bib6-20250802","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1148\/radiol.2018171105","article-title":"Accumulation of gadolinium in human cerebrospinal fluid after gadobutrol-enhanced MR imaging: a prospective observational cohort study","volume":"288","year":"2018","journal-title":"Radiology"},{"key":"bib7-20250802","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1148\/radiol.2020192645","article-title":"Gadolinium retention in the central and peripheral nervous system: implications for pain, cognition, and neurogenesis","volume":"297","year":"2020","journal-title":"Radiology"},{"key":"bib8-20250802","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1016\/j.mri.2016.07.016","article-title":"Gadolinium deposition disease: initial description of a disease that has been around for a while","volume":"34","year":"2016","journal-title":"Magn Reson Imaging"},{"key":"bib9-20250802","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1016\/j.mri.2016.09.005","article-title":"Gadolinium toxicity and treatment","volume":"34","year":"2016","journal-title":"Magn Reson Imaging"},{"key":"bib10-20250802","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1016\/j.mri.2016.05.005","article-title":"Self-reported gadolinium toxicity: a survey of patients with chronic symptoms","volume":"34","year":"2016","journal-title":"Magn Reson Imaging"},{"key":"bib11-20250802","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1002\/art.24471","article-title":"Induction of the expression of profibrotic cytokines and growth factors in normal human peripheral blood monocytes by gadolinium contrast agents","volume":"60","year":"2009","journal-title":"Arthritis Rheum"},{"key":"bib12-20250802","first-page":"113","article-title":"Induction of a type I interferon signature in normal human monocytes by gadolinium-based contrast agents: comparison of linear and macrocyclic agents","volume":"175","year":"2014","journal-title":"Clin Exp Immunol"},{"key":"bib13-20250802","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1590\/0100-3984.2019.0075","article-title":"An initial investigation of serum cytokine levels in patients with gadolinium retention","volume":"53","year":"2020","journal-title":"Radiol Bras"},{"key":"bib14-20250802","doi-asserted-by":"crossref","first-page":"6420","DOI":"10.1007\/s11356-019-07108-4","article-title":"Exposure to arsenic and lead in children from Salamanca M\u00e9xico, effects on telomeric lengthening and mitochondrial DNA","volume":"27","year":"2020","journal-title":"Environ Sci Pollut Res Int"},{"key":"bib15-20250802","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.chemosphere.2016.08.011","article-title":"A review of human biomonitoring studies of trace elements in Pakistan","volume":"163","year":"2016","journal-title":"Chemosphere"},{"key":"bib16-20250802","doi-asserted-by":"crossref","first-page":"212","DOI":"10.2166\/wh.2018.070","article-title":"Arsenic, cadmium, lead, and chromium in well water, rice, and human urine in Sri Lanka in relation to chronic kidney disease of unknown etiology","volume":"16","year":"2018","journal-title":"J Water Health"},{"key":"bib17-20250802","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1097\/RLI.0000000000000453","article-title":"Intravenous calcium\u2212\/zinc-diethylene triamine penta-acetic acid in patients with presumed gadolinium deposition disease: a preliminary report on 25 patients","volume":"53","year":"2018","journal-title":"Invest Radiol"},{"key":"bib18-20250802","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/0162-3109(93)90062-U","article-title":"Effect of mycophenolate mofetil (RS-61443) on cytokine production: inhibition of superantigen-induced cytokines","volume":"26","year":"1993","journal-title":"Immunopharmacology"},{"key":"bib19-20250802","doi-asserted-by":"crossref","first-page":"229","DOI":"10.2214\/AJR.15.15842","article-title":"Gadolinium in humans: a family of disorders","volume":"207","year":"2016","journal-title":"AJR Am J Roentgenol"},{"key":"bib20-20250802","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1038\/s41597-019-0213-4","article-title":"The FluPRINT dataset, a multidimensional analysis of the influenza vaccine imprint on the immune system","volume":"6","year":"2019","journal-title":"Sci Data"},{"key":"bib21-20250802","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.cell.2014.12.020","article-title":"Variation in the human immune system is largely driven by non-heritable influences","volume":"160","year":"2015","journal-title":"Cell"},{"key":"bib22-20250802","doi-asserted-by":"crossref","first-page":"26996","DOI":"10.1038\/srep26996","article-title":"The statistical value of raw fluorescence signal in Luminex xMAP based multiplex immunoassays","volume":"6","year":"2016","journal-title":"Sci Rep"},{"key":"bib23-20250802","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1148\/radiol.2018171398","article-title":"Dentate nucleus signal intensity decrease on T1-weighted MR images after switching from gadopentetate dimeglumine to gadobutrol","volume":"287","year":"2018","journal-title":"Radiology"},{"key":"bib24-20250802","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1097\/RLI.0000000000000352","article-title":"Quantification and assessment of the chemical form of residual gadolinium in the brain after repeated administration of gadolinium-based contrast agents: comparative study in rats","volume":"52","year":"2017","journal-title":"Invest Radiol"},{"key":"bib25-20250802","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1097\/RLI.0000000000000522","article-title":"Impact of treatment with chelating agents depends on the stability of administered GBCAs: a comparative study in rats","volume":"54","year":"2019","journal-title":"Invest Radiol"},{"key":"bib26-20250802","doi-asserted-by":"crossref","first-page":"376","DOI":"10.2214\/AJR.07.3280","article-title":"Frequency of serum creatinine changes in the absence of iodinated contrast material: implications for studies of contrast nephrotoxicity","volume":"191","year":"2008","journal-title":"AJR Am J Roentgenol"},{"key":"bib27-20250802","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1097\/RLI.0000000000000280","article-title":"Revisiting the pharmacokinetic profiles of gadolinium-based contrast agents: differences in long-term biodistribution and excretion","volume":"51","year":"2016","journal-title":"Invest Radiol"},{"key":"bib28-20250802","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1056\/NEJMoa2004114","article-title":"RNA identification of PRIME cells predicting rheumatoid arthritis flares","volume":"383","year":"2020","journal-title":"N Engl J Med"},{"key":"bib29-20250802","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1080\/15563650.2019.1681442","article-title":"Gadolinium-based contrast agents\u2014what is the evidence for \u201cgadolinium deposition disease\u201d and the use of chelation therapy?","volume":"58","year":"2020","journal-title":"Clin Toxicol"},{"key":"bib30-20250802","first-page":"E7150","article-title":"Cytokine signature associated with disease severity in chronic fatigue syndrome patients","volume":"114","year":"2017","journal-title":"Proc Natl Acad Sci U S A"},{"key":"bib31-20250802","article-title":"Cytokine profile in plasma of severe COVID-19 does not differ from ARDS and sepsis","volume":"5","year":"2020","journal-title":"JCI Insight"},{"key":"bib32-20250802","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1186\/s12967-019-1947-7","article-title":"Cytokine expression in Treponema pallidum infection","volume":"17","year":"2019","journal-title":"J Transl Med"},{"key":"bib33-20250802","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.cyto.2016.09.021","article-title":"Cytokine profiles in patients with toxoplasmic lymphadenitis in the setting of pregnancy","volume":"90","year":"2017","journal-title":"Cytokine"},{"key":"bib34-20250802","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.bbmt.2013.11.026","article-title":"Cytokine and chemokine patterns across 100 days after hematopoietic stem cell transplantation in children","volume":"20","year":"2014","journal-title":"Biol Blood Marrow Transplant"},{"key":"bib35-20250802","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1016\/j.jash.2015.10.003","article-title":"Cytokines profile in hypertensive patients with left ventricular remodeling and dysfunction","volume":"9","year":"2015","journal-title":"J Am Soc Hypertens"},{"key":"bib36-20250802","first-page":"683","article-title":"The skin-brain connection hypothesis, bringing together CCL27-mediated T-cell activation in the skin and neural cell damage in the adult brain","volume":"7","year":"2016","journal-title":"Front Immunol"},{"key":"bib37-20250802","doi-asserted-by":"crossref","first-page":"3813","DOI":"10.2741\/2354","article-title":"TRAIL: a multifunctional cytokine","volume":"12","year":"2007","journal-title":"Front Biosci"},{"key":"bib38-20250802","first-page":"e22546","article-title":"The role of soluble CD40L in immunosuppression","volume":"2","year":"2013","journal-title":"Onco Targets Ther"},{"issue":"suppl 2","key":"bib39-20250802","first-page":"21","article-title":"Review of epidermal growth factor receptor biology","volume":"59","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"bib40-20250802","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.cytogfr.2004.01.004","article-title":"The role of epidermal growth factor and its receptors in mammalian CNS","volume":"15","year":"2004","journal-title":"Cytokine Growth Factor Rev"},{"key":"bib41-20250802","article-title":"Hepatocyte growth factor activator: a proteinase linking tissue injury with repair","volume":"19","year":"2018","journal-title":"Int J Mol Sci"},{"key":"bib42-20250802","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1089\/jwh.2015.5509","article-title":"Association of leptin with body pain in women","volume":"25","year":"2016","journal-title":"J Womens Health (Larchmt)"},{"key":"bib43-20250802","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1186\/1479-5876-11-93","article-title":"Daily cytokine fluctuations, driven by leptin, are associated with fatigue severity in chronic fatigue syndrome: evidence of inflammatory pathology","volume":"11","year":"2013","journal-title":"J Transl Med"},{"key":"bib44-20250802","doi-asserted-by":"crossref","first-page":"2522","DOI":"10.1111\/bcp.13718","article-title":"Gadolinium deposition and the potential for toxicological sequelae\u2014a literature review of issues surrounding gadolinium-based contrast agents","volume":"84","year":"2018","journal-title":"Br J Clin Pharmacol"},{"key":"bib45-20250802","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/s10534-016-9931-7","article-title":"Gadolinium-based contrast agent toxicity: a review of known and proposed mechanisms","volume":"29","year":"2016","journal-title":"Biometals"},{"key":"bib46-20250802","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1097\/RLI.0000000000000567","article-title":"Gadolinium-based MRI contrast agents induce mitochondrial toxicity and cell death in human neurons, and toxicity increases with reduced kinetic stability of the agent","volume":"54","year":"2019","journal-title":"Invest Radiol"},{"key":"bib47-20250802","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.neuro.2010.04.003","article-title":"Impaired mitochondrial function and oxidative stress in rat cortical neurons: implications for gadolinium-induced neurotoxicity","volume":"31","year":"2010","journal-title":"Neurotoxicology"}],"container-title":["Investigative Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/RLI.0000000000000752","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T20:02:14Z","timestamp":1754164934000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/RLI.0000000000000752"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,15]]},"references-count":47,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/rli.0000000000000752","relation":{},"ISSN":["1536-0210","0020-9996"],"issn-type":[{"value":"1536-0210","type":"electronic"},{"value":"0020-9996","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1,15]]}}}